A Call for Increased Flexibility in Current Teratogenicity Testing
The testing of new drugs and chemicals for the potential risk they might pose for the human population is a very difficult proposition. In the field of developmental toxicity this task is more difficult due to the added complexity of species differences in embryogenesis and the placental interface.
KeywordsCytosine Arabinoside Developmental Toxicity Pragmatic Consideration Hazard Identification Limb Malformation
Unable to display preview. Download preview PDF.
- Hirsch KS, Scott WJ (1983) Searching for the mechanism of acetazolamide teratogenesis. In: H. Kalter (ed), Issues and Reviews in Teratology, Plenum Press, New York, pp 309–347.Google Scholar
- Wilson JG (1975) Critique of current methods for teratogenicity testing in animals and suggestions for their improvement. In: T. Shepard, J. Miller, M. Marois (eds), Methods for detection of environmental agents that produce congenital defects, North-Holland/American Elsevier, New York, pp 29–57.Google Scholar